Internal Medicine, Rheumatology · Duncansville, PA
NPI
1205834397
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
175 Meadowbrook Ln
Duncansville, PA, 16635
Phone (814) 693-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
132,459 services
Medicare patients, 2024
839
Average age 73
Drug cost, 2024
$6.8M
8,875 prescriptions
Company payments, 2025
$53K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frederick T Murphy was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 76,000 times for 29 patients. In total Frederick T Murphy billed 132,459 services in 116 codes, and Medicare paid $1.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 76,000 | 29 | $3.63 | $276K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 6,680 | 68 | $0.10 | $680 |
| J0897 Injection, denosumab, 1 mg | Office | 5,700 | 61 | $20.49 | $117K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 5,500 | 11 | $9.17 | $50K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 4,800 | 18 | $33.86 | $163K |
| 85025 Blood Count | Office | 1,377 | 727 | $7.53 | $10K |
| 85651 Clinical Chemistry | Office | 1,345 | 719 | $4.14 | $5,564 |
| 36415 Venipuncture Blood Collection | Office | 1,334 | 709 | $8.63 | $12K |
| 86140 Clinical Chemistry | Office | 1,302 | 704 | $5.03 | $6,547 |
| 82565 Clinical Chemistry | Office | 1,261 | 666 | $4.97 | $6,264 |
| 84460 Clinical Chemistry | Office | 1,254 | 667 | $5.17 | $6,480 |
| 84450 Clinical Chemistry | Office | 1,254 | 667 | $5.03 | $6,303 |
| 99214 Office E&M - Established | Office | 1,245 | 702 | $85.34 | $106K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,125 | 14 | $0.23 | $257 |
| 82040 Clinical Chemistry | Office | 804 | 530 | $4.81 | $3,865 |
By year: 2022 $1.1M for 99,908 services; 2023 $1.3M for 107,730 services; 2024 $1.6M for 132,459 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,377 | 727 | $7.53 | $10K |
| 85651 Clinical Chemistry | 1,345 | 719 | $4.14 | $5,564 |
| 36415 Venipuncture Blood Collection | 1,334 | 709 | $8.63 | $12K |
| 86140 Clinical Chemistry | 1,302 | 704 | $5.03 | $6,547 |
| 82565 Clinical Chemistry | 1,261 | 666 | $4.97 | $6,264 |
| 84450 Clinical Chemistry | 1,254 | 667 | $5.03 | $6,303 |
| 84460 Clinical Chemistry | 1,254 | 667 | $5.17 | $6,480 |
| 82040 Clinical Chemistry | 804 | 530 | $4.81 | $3,865 |
| 86235 Immunoassay | 522 | 99 | $17.21 | $8,982 |
| 84550 Clinical Chemistry | 201 | 143 | $4.37 | $879 |
Medicare prescription drug claims, 2024
In 2024, the drug Frederick T Murphy prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,363 prescriptions and refills. In total Frederick T Murphy wrote 8,875 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,363 | 3,672 | 559 | $73K |
| Methotrexate Methotrexate Sodium | 989 | 2,456 | 367 | $38K |
| Tramadol Hcl Generic | 755 | 765 | 165 | $5,987 |
| Prednisone Generic | 709 | 1,699 | 282 | $5,230 |
| Methylprednisolone Generic | 373 | 808 | 188 | $7,461 |
| Meloxicam Generic | 369 | 996 | 182 | $2,253 |
| Gabapentin Generic | 343 | 747 | 138 | $5,607 |
| Celecoxib Generic | 323 | 805 | 137 | $10K |
| Pregabalin Generic | 290 | 309 | 52 | $6,501 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 273 | 273 | 49 | $4,531 |
| Duloxetine Hcl Generic | 267 | 726 | 120 | $10K |
| Rinvoq Upadacitinib | 190 | 248 | 39 | $1.6M |
| Alendronate Sodium Generic | 162 | 344 | 63 | $1,532 |
| Allopurinol Generic | 145 | 392 | 51 | $2,428 |
| Leflunomide Generic | 129 | 291 | 45 | $9,953 |
Brand drugs: - claims; generic drugs: 7,746 claims; opioid claims: 1,137.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frederick T Murphy $53K ($53K in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $50K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 248 | $50K |
| Amgen Inc. AMGN | 34 | $614 |
| Janssen Biotech, Inc. JNJ | 30 | $459 |
| Pfizer Inc. PFE | 43 | $333 |
| UCB, Inc. UCB.BR | 29 | $317 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $270 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $235 |
| GlaxoSmithKline, LLC. GSK | 13 | $210 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $126 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $74.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.